Veterinary Medicines

Pathocef 25 mg/ml intramammary suspension

Not authorised
  • Cefoperazone sodium
Download as PDF

Product identification

Medicine name:
Pathocef 25 mg/ml intramammary suspension
Active substance:
  • Cefoperazone sodium
Target species:
  • Cattle
Route of administration:
  • Intramammary use

Product details

Active substance and strength:
  • Cefoperazone sodium
    25.85
    milligram(s)
    /
    1.00
    millilitre(s)
Pharmaceutical form:
  • Intramammary suspension
Withdrawal period by route of administration:
  • Intramammary use
    • Cattle
      • Meat and offal
        2
        day
      • Milk
        72
        hour
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QJ51DD12
Legal status of supply:
  • Veterinary medicinal product subject to veterinary prescription
Authorisation status:
  • Surrendered
Authorised in:
  • Ireland
Package description:
  • 12 ml low density polyethylene syringe (containing 10 ml intramammary suspension) fitted with a protective cap of red low density polyethylene. Cartons of 4 syringes.

Additional information

Entitlement type:
  • Marketing Authorisation
Legal basis of product authorisation:
  • Full application (Article 12(3) of Directive No 2001/82/EC)
Marketing authorisation holder:
  • Zoetis Belgium S.A.
Marketing authorisation date:
Manufacturing sites for batch release:
  • Haupt Pharma Latina S.r.l.
Responsible authority:
  • Health Products Regulatory Authority
Authorisation number:
  • VPA10387/047/001
Date of authorisation status change:

Documents

Summary of Product Characteristics

English (PDF)
Published on: 3/05/2024
Download